That's right, I struggle to find potential revenue for AT1 except for the FDA approval for Febridx. Other new products would take a lot more time with the way AT1 gets regulatory approvals.
speaking of Febridx, man, LDX has been brutal lol. I should not get back in after I took a tiny loss with my first entry. Got back in at 70cent then 56 cents, now is close to 30 cents. In such a short period and it is a straight line down, not even able to trade it to cover some loss
I guess I made the same mistake there like AT1 is to putting bets on a concept rather than waiting till it comes to fruition. Lesson's learned.
That's right, I struggle to find potential revenue for AT1...
Add AT1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.1¢ |
Change
0.001(3.33%) |
Mkt cap ! $19.81M | |||
| Open | High | Low | Value | Volume |
| 3.0¢ | 3.1¢ | 2.9¢ | $4.745K | 159.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 123968 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.1¢ | 53324 | 2 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
3.1¢ |
Change
0.001 ( 3.33 %) |
||||
| Open | High | Low | Volume | ||
| 3.0¢ | 3.1¢ | 2.9¢ | 32795 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| AT1 (ASX) Chart |